<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="the deployment of novel universal vaccines against epidemic and pandemic" exact="influenza" post="Deployment of novel UIVs against influenza http://orcid.org/0000-0001-9502-6876ArinaminpathyN.1RileyS.1BarclayW. S.2Saad-RoyC.3GrenfellB.4[1], MRC"/>
 <result pre="against epidemic and pandemic influenza Deployment of novel UIVs against" exact="influenza" post="http://orcid.org/0000-0001-9502-6876ArinaminpathyN.1RileyS.1BarclayW. S.2Saad-RoyC.3GrenfellB.4[1], MRC Centre for Global Infectious Disease Analysis,"/>
 <result pre="There is increasing interest in the development of new, ‘universal’" exact="influenza" post="vaccines (UIVs) that––unlike current vaccines––are effective against a broad"/>
 <result pre="that––unlike current vaccines––are effective against a broad range of seasonal" exact="influenza" post="strains, as well as against novel pandemic viruses. While"/>
 <result pre="development will be invaluable in developing robustly predictive modelling approaches." exact="influenza" post="epidemiology mathematical modelling vaccine Funding Medical Research Councilhttp://dx.doi.org/10.13039/501100000265 MR/R015600/1"/>
 <result pre="Funding Medical Research Councilhttp://dx.doi.org/10.13039/501100000265 MR/R015600/1 1. Introduction Current vaccines against" exact="influenza" post="have had considerable impact [1], but their efficacy depends"/>
 <result pre="on a close match between the vaccine and the circulating" exact="influenza" post="virus, in particular to the immunodominant ‘head’ region of"/>
 <result pre="can provide more broad, long-lasting protection against seasonal and pandemic" exact="influenza" post="viruses [2,3]. Several such ‘universal’ influenza vaccines (UIVs) are"/>
 <result pre="against seasonal and pandemic influenza viruses [2,3]. Several such ‘universal’" exact="influenza" post="vaccines (UIVs) are currently in development (table 1) [14];"/>
 <result pre="(table 1) [14]; they may offer qualitatively new opportunities for" exact="influenza" post="control, raising the prospect of routine vaccination programmes that"/>
 <result pre="pandemic viruses. Table 1. Summary of different immune targets for" exact="influenza" post="vaccines. Among current influenza vaccines, ‘inactivated’ vaccines focus on"/>
 <result pre="Summary of different immune targets for influenza vaccines. Among current" exact="influenza" post="vaccines, ‘inactivated’ vaccines focus on HA1 immunity (top row),"/>
 <result pre="of mass deployment of UIVs [15,16]. However, population immunity to" exact="influenza" post="is complex and incompletely understood, raising the possibility of"/>
 <result pre="using a simple mathematical model capturing some essential features of" exact="influenza" post="transmission and immunity, we present two theoretical examples of"/>
 <result pre="population's vulnerability to influenza. In the face of uncertainties surrounding" exact="influenza" post="immunity, we discuss key areas that future work should"/>
 <result pre="currently has the world's largest population (all-age) coverage of seasonal" exact="influenza" post="vaccination [17]. Building on earlier work [18], we develop"/>
 <result pre="on earlier work [18], we develop a simple model of" exact="influenza" post="immunity and transmission dynamics in the USA (see electronic"/>
 <result pre="exceeds 40% of the population [17]. The development of universal" exact="influenza" post="vaccines is still in its early stages; in the"/>
 <result pre="standard ‘critical vaccination threshold’ required to interrupt transmission of seasonal" exact="influenza" post="(roughly 66% needing to be effectively vaccinated for a"/>
 <result pre="although vaccination has offered great benefits in the control of" exact="influenza" post="for several decades, new technologies may offer qualitatively new"/>
 <result pre="several decades, new technologies may offer qualitatively new opportunities for" exact="influenza" post="control. In view of the complex effects that UIVs"/>
 <result pre="vaccine: the challenge of antigenic drift. Vaccine25, 6852–6862. (10.1016/j.vaccine.2007.07.027)17719149 3FedsonDS2003Pandemic" exact="influenza" post="and the global vaccine supply. Clin. Infect. Dis.36, 1552–1561."/>
 <result pre="Dis.36, 1552–1561. (10.1086/375056)12802755 4OsterholmMT, KelleyNS, SommerA, BelongiaEA2012Efficacy and effectiveness of" exact="influenza" post="vaccines: a systematic review and meta-analysis. Lancet Infect. Dis.12,"/>
 <result pre="Dis.12, 36–44. (10.1016/S1473-3099(11)70295-X)22032844 5BelongiaEA, SimpsonMD, KingJP, SundaramME, KelleyNS, OsterholmMT, McLeanHQ2016Variable" exact="influenza" post="vaccine effectiveness by subtype: a systematic review and meta-analysis"/>
 <result pre="6ThompsonCPet al.2018A naturally protective epitope of limited variability as an" exact="influenza" post="vaccine target. Nat. Commun.9, 1–10. (10.1038/s41467-018-06228-8)29317637 7CarterDMet al.2016Design and"/>
 <result pre="of a computationally optimized broadly reactive hemagglutinin vaccine for H1N1" exact="influenza" post="viruses. J. Virol.90, 4720–4734. (10.1128/jvi.03152-15)26912624 8ImpagliazzoAet al.2015A stable trimeric"/>
 <result pre="influenza viruses. J. Virol.90, 4720–4734. (10.1128/jvi.03152-15)26912624 8ImpagliazzoAet al.2015A stable trimeric" exact="influenza" post="hemagglutinin stem as a broadly protective immunogen. Science349, 1301–1306."/>
 <result pre="9MargineIet al.2013Hemagglutinin stalk-based universal vaccine constructs protect against group 2" exact="influenza" post="A viruses. J. Virol.87, 10 435–10 446. (10.1128/JVI.01715-13) 10KrammerF,"/>
 <result pre="M1 proteins as immunogens in DNA- and vaccinia virus-based universal" exact="influenza" post="A virus vaccines in mice. Clin. Vaccine Immunol.22, 618–630."/>
 <result pre="(10.1128/CVI.00091-15)25834017 12PriceGE, LoC-Y, MisplonJA, EpsteinSL2014Mucosal immunization with a candidate universal" exact="influenza" post="vaccine reduces virus transmission in a mouse model. J."/>
 <result pre="14ErbeldingEJ, PostDJ, StemmyEJ, RobertsPC, AugustineAD, FergusonS, PaulesCI, GrahamBS, FauciAS2018A universal" exact="influenza" post="vaccine: the strategic plan for the National Institute of"/>
 <result pre="GrahamAL, GrenfellBT, ArinaminpathyN2016Universal or specific? A modeling-based comparison of broad-spectrum" exact="influenza" post="vaccines against conventional, strain-matched vaccines. PLoS Comput. Biol.12, e1005204"/>
 <result pre="HaberM, FoppaIM, GambhirM, BreseeJ2017Estimating direct and indirect protective effect of" exact="influenza" post="vaccination in the United States. Am. J. Epidemiol.186, 92–100."/>
 <result pre="States. Am. J. Epidemiol.186, 92–100. (10.1093/aje/kwx037)28369163 19EpsteinSL, PriceGE2010Cross-protective immunity to" exact="influenza" post="A viruses. Expert Rev. Vaccines9, 1325–1341. (10.1586/erv.10.123)21087110 20EkiertDC, BhabhaG,"/>
 <result pre="FriesenRHE, JongeneelenM, ThrosbyM, GoudsmitJ, WilsonIA2009Antibody recognition of a highly conserved" exact="influenza" post="virus epitope. Science324, 246–251. (10.1126/science.1171491)19251591 21DreyfusC, EkiertDC, WilsonIA2013Structure of"/>
 <result pre="broadly neutralizing stem antibody in complex with a pandemic H2" exact="influenza" post="virus hemagglutinin. J. Virol.87, 7149–7154. (10.1128/JVI.02975-12)23552413 22BodewesRet al.2011Annual vaccination"/>
 <result pre="virus hemagglutinin. J. Virol.87, 7149–7154. (10.1128/JVI.02975-12)23552413 22BodewesRet al.2011Annual vaccination against" exact="influenza" post="virus hampers development of virus-specific CD8+ T cell immunity"/>
 <result pre="de WitE, Geelhoed-MierasMM, BoonACM, SymonsJ, FouchierRAM, OsterhausADME, RimmelzwaanGF.2005Functional constraints of" exact="influenza" post="A virus epitopes limit escape from cytotoxic T lymphocytes."/>
 <result pre="the structural and functional constraints for immune evasion: insights from" exact="influenza" post="virus. J. Mol. Biol.429, 2694–2709. (10.1016/j.jmb.2017.06.015)28648617 25DoudMB, LeeJM, BloomJD2018How"/>
 <result pre="affect viral escape from broad and narrow antibodies to H1" exact="influenza" post="hemagglutinin. Nat. Commun.9, 1386 (10.1038/s41467-018-03665-3)29643370 26FineP, EamesK, HeymannDL2011‘Herd immunity’:"/>
 <result pre="27HenryC, PalmAKE, KrammerF, WilsonPC2018From original antigenic sin to the universal" exact="influenza" post="virus vaccine. Trends Immunol.39, 70–79. (10.1016/j.it.2017.08.003)28867526 28LesslerJ, RileyS, ReadJM,"/>
 <result pre="WangS, ZhuH, SmithGJD, GuanY, JiangCQ, CummingsDAT2012Evidence for antigenic seniority in" exact="influenza" post="A (H3N2) antibody responses in southern China. PLoS Pathog.8,"/>
 <result pre="(10.1371/journal.ppat.1002802)22829765 29GosticKM, AmbroseM, WorobeyM, Lloyd-SmithJO2016Potent protection against H5N1 and H7N9" exact="influenza" post="via childhood hemagglutinin imprinting. Science354, 722–726. (10.1126/science.aag1322)27846599"/>
</results>
